Our Promise to You
"One of the nation's premier plaintiffs' firms."
"Representing the best qualities of the plaintiffs' bar."
The National Law Journal
"Their effective and caring advocacy for clients has earned Lieff Cabraser its first-class reputation."
The Daily Journal
- Issue: Dangerous prescription drug side-effects
Psoriasis Drug Raptiva Linked to Patient Deaths
On April 8, 2009, the U.S. Food and Drug Administration (FDA) issued a safety alert for the prescription drug Raptiva, a medication for treatment of psoriasis manufactured by Genentech, Inc. The Raptiva recall was the result of serious Raptiva side effects, including patients developing progressive multifocal leukoencephalopathy (PML).
PML is a viral infection that damages the protective sheath surrounding nerves. PML is often fatal. Symptoms include weakness, loss of coordination, changes in vision, difficulty speaking and personality changes, and there is no known treatment.
In February 2009, the FDA reported that patients using the psoriasis drug Raptiva had died of a rare brain infection. At the time, the FDA reported that four people taking Raptiva contracted PML, and that three of the patients died.
Raptiva Lawsuits: Legal Rights of Patients Injured by Raptiva
The law in most states provides several personal injury claims for persons who have been seriously injured by a prescription drug manufactured defectively. These claims include strict liability for a defective product, breach of warranty, negligence, and misrepresentation. Damages sought against pharmaceutical companies for dangerous drug side effects and injuries include:
- Physical pain and suffering, mental anguish and physical impairment;
- Medical expenses associated with efforts to remedy the injuries as a result of the original surgery; and
- Loss of earnings and/or earning capacity.
In the case of a patient's death, the family of the victim may file a wrongful death action and seek damages.
Contact Lieff Cabraser
If you or a loved one have suffered a serious injury following the use of Raptiva or are a relative of a patient who died after receiving Raptiva, please click here to contact an experienced personal injury attorney at the national law firm of Lieff Cabraser.
Or you may call us toll-free at 1-800-541-7358 and ask to speak to attorney Heather A. Foster.
FDA Raptiva Withdrawal Notice Documents
- April 08, 2009 - Dear Healthcare Professional Letter - Genentech
- April 08, 2009 - Dear Patient Letter - Genentech
- April 08, 2009 - Statement - FDA
- February 19, 2009 - Public Health Advisory - FDA
- February 19, 2009 - News Release - FDA
Raptiva is a Trademark of Genentech and is used herein for informational and product identification purposes only. Lieff Cabraser is not affiliated with Genentech.